CareDx ( (CDNA) ) has shared an update.
CareDx, Inc., a leading precision medicine solutions company in the transplant space, has announced the strategic appointments of Keith Kennedy as Chief Operating Officer and Jessica Meng as Chief Commercial Officer. Kennedy brings over two decades of healthcare leadership experience, aiming to drive the company’s operational excellence, while Meng’s deep commercial expertise is set to propel CareDx’s global commercial growth. The company is gearing up to share its long-term strategic growth plan during an Investor Day in October 2024. These executive team enhancements are aligned with CareDx’s mission to deliver high-value healthcare solutions for transplant patients and caregivers.
For a thorough assessment of CDNA stock, go to TipRanks’ Stock Analysis page.
